Patent · US Active

Regenerative tissue grafts and methods of making same

US10507187B2 · kind B2 · utility

1Cited by
1References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 12, 2014
Grant dateDec 17, 2019
Priority date
Expiry dateFeb 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A graft containing a scaffold that includes a matrix in which are positioned mesenchymal progenitor cells (MPCs) has the capacity to substantially improve wound healing, including wounds resulting from injury to nerve, bone and vascular tissue. MPCs can be harvested from debrided muscle tissue following orthopaedic trauma. The traumatized muscle-derived progenitor cells are a readily available autologous cell source that can be utilized to effect or improve wound healing in a variety of therapeutic settings and vehicles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.